173,349 results on '"Diabetes Mellitus, type 2"'
Search Results
2. YKL-40, cardiovascular events, and mortality in individuals recently diagnosed with type 2 diabetes: A Danish cohort study
3. SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysis
4. Phase II Study of PG-102(MG12) Compared with Placebo in Obesity and Type 2 Diabetes
5. A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor (ACHIEVE-5)
6. A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
7. A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD)
8. Type 2 Continuous Glucose Monitoring Academy
9. A Research Study to See How Much CagriSema (1.0 mg Once Weekly) Lowers Blood Sugar and Body Weight Compared to Tirzepatide (5 mg Once Weekly) in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both (REIMAGINE 5)
10. A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin (REIMAGINE 3)
11. Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes (B-LIFT)
12. Stem Cell Therapy for Chronic Kidney Disease
13. Cross-Sectional and Longitudinal Studies of 'Pre-Diabetes' in the Pima Indians
14. Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix
15. Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs (C5CAMP)
16. Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
17. Exercise Training and Type 2 Diabetes
18. Mechanisms of Diabetic Kidney Disease in American Indians
19. Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)
20. An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
21. Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes (SFRNDM2)
22. Forearm Immobilization in T2D (FIT2D)
23. A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
24. STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes
25. FreeStyle Libre Monitoring in T2DM
26. XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
27. A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
28. Decreasing Cardiovascular Risk for Patients With Diabetes
29. Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
30. Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
31. Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
32. Emulation of the SOUL Diabetes Trial in Healthcare Claims
33. A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (CONFIDENCE)
34. iCaReMe Global Registry (iCaReMe)
35. SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
36. Enhancing Telemedicine for T2D
37. A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
38. A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
39. A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events (TRANSFORM)
40. Antidiabetic Drugs for Steatotic Liver Disease
41. Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic Patients
42. SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes (START)
43. Driving with Neuropathy
44. Efficacy and Safety of Semaglutide Injection Vs Ozempic® in Patients with Type 2 Diabetes
45. A Tissue Sparing, Laser Assisted Penile Prosthesis Implantation Technique (TSLA)
46. A Study of CT-388 in Participants Who Are Overweight or Obese with Type 2 Diabetes Mellitus
47. Intestinal Metabolic Reprogramming As a Key Mechanism of Gastric Bypass in Humans
48. Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness (CV-Homes)
49. A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight (REDEFINE 2)
50. A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients (SMART-Finder)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.